Tema Heart & Health ETF (HRTS)
NASDAQ: HRTS · Real-Time Price · USD
33.34
-0.55 (-1.64%)
May 15, 2026, 4:00 PM EDT - Market closed
HRTS Holdings Information
HRTS is an equity ETF with a total of 46 individual holdings. The top holdings are Eli Lilly and Company stock at 10.65%, UnitedHealth Group at 5.59%, Novo Nordisk at 5.43%, Roche Holding AG at 4.47%, and Merck & Co. at 4.14%.
Total Holdings
46
Top 10 Percentage
48.51%
Asset Class
Equity
ETF Category
Health
Assets
51.25M
PE Ratio
20.51
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 10.65% |
| 2 | UNH | UnitedHealth Group Incorporated | 5.59% |
| 3 | CPH: NOVO.B | Novo Nordisk A/S | 5.43% |
| 4 | RHHBY | Roche Holding AG | 4.47% |
| 5 | MRK | Merck & Co., Inc. | 4.14% |
| 6 | LON: AZN | AstraZeneca PLC | 4.02% |
| 7 | JNJ | Johnson & Johnson | 3.73% |
| 8 | TMO | Thermo Fisher Scientific Inc. | 3.67% |
| 9 | GILD | Gilead Sciences, Inc. | 3.42% |
| 10 | SWX: NOVN | Novartis AG | 3.39% |
| 11 | RVMD | Revolution Medicines, Inc. | 3.21% |
| 12 | VRTX | Vertex Pharmaceuticals Incorporated | 2.99% |
| 13 | BBIO | BridgeBio Pharma, Inc. | 2.77% |
| 14 | ABT | Abbott Laboratories | 2.62% |
| 15 | DHR | Danaher Corporation | 2.43% |
| 16 | ABBV | AbbVie Inc. | 2.35% |
| 17 | CYTK | Cytokinetics, Incorporated | 2.21% |
| 18 | BMY | Bristol-Myers Squibb Company | 2.10% |
| 19 | TEVA | Teva Pharmaceutical Industries Limited | 2.09% |
| 20 | MDT | Medtronic plc | 1.99% |
| 21 | REGN | Regeneron Pharmaceuticals, Inc. | 1.96% |
| 22 | AMGN | Amgen Inc. | 1.94% |
| 23 | MDGL | Madrigal Pharmaceuticals, Inc. | 1.87% |
| 24 | MCK | McKesson Corporation | 1.75% |
| 25 | EW | Edwards Lifesciences Corporation | 1.67% |
As of May 13, 2026